Device Trial Radar · NCT06797258
FlexHD® Pliable Investigation in Implant-Based Breast Reconstruction
Last checked: Nov 21, 2026Latest source record: Apr 2, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
259
Planned (sponsor's estimate)
Start
Mar 26, 2025
Primary completion
Aug 2027
Study completion Aug 2027
Sponsor
- Lead sponsor
- Musculoskeletal Transplant FoundationAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- MCRA (an IQVIA business); Bruder Consulting International, LLC
- First posted
- Jan 28, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- Female only, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Prospective, multi-center, single-arm clinical study in females undergoing immediate implant-based breast reconstruction using a pre-pectoral technique
Conditions
- Implant Based Breast Reconstruction
Interventions
FlexHD® PliableDevice
Acellular Dermal Matrix
No interventionOther
Historical Control Arm
Primary outcomes
What the sponsor says the trial is designed to measure.
- Frequency of major complicationTime frame: 12 months
1 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Jonathan Heistein, MD Plastic & Reconstructive Surgery
Fort Worth, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.